Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAS
Basis Energy Services, Inc.
BAS
|
+$159M |
| 2 |
Freeport-McMoran
FCX
|
+$137M |
| 3 |
Walt Disney
DIS
|
+$129M |
| 4 |
Alcoa
AA
|
+$98.7M |
| 5 |
CMA
Comerica
CMA
|
+$87.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$187M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$177M |
| 3 |
ANDV
Andeavor
ANDV
|
+$166M |
| 4 |
Canadian Pacific Kansas City
CP
|
+$160M |
| 5 |
Union Pacific
UNP
|
+$140M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.65% |
| 2 | Consumer Discretionary | 12.25% |
| 3 | Healthcare | 12.08% |
| 4 | Energy | 7.79% |
| 5 | Materials | 6.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Chevron
CVX
$398B
| $3.86M | 0.02% |
32,798
+30,842
| +1,577% | +$3.36M |
|
752
Global Payments
GPN
$25B
| $3.86M | 0.02% |
+55,590
| New | +$3.99M |
|
|
PRTK
753
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.85M | 0.02% |
+250,300
| New | +$3.25M |
|
754
Compañía de Minas Buenaventura
BVN
$8.94B
| $3.83M | 0.02% |
+339,077
| New | +$4.05M |
|
|
PGRE
755
DELISTED
Paramount Group
PGRE
| $3.82M | 0.02% |
239,069
-120,441
| -34% | -$1.9M |
|
756
Sunstone Hotel Investors
SHO
$2.1B
| $3.81M | 0.02% |
+249,904
| New | +$3.48M |
|
757
CALL
Oracle
ORCL
$410B
| $3.81M | 0.02% |
+99,000
| New | +$3.87M |
|
|
XLNX
758
CALL
DELISTED
Xilinx Inc
XLNX
| $3.8M | 0.02% |
+63,000
| New | +$3.38M |
|
759
Conagra Brands
CAG
$8B
| $3.8M | 0.02% |
+96,098
| New | +$3.59M |
|
|
DPLO
760
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $3.79M | 0.02% |
+301,215
| New | +$5.61M |
|
761
Bio-Rad Laboratories Class A
BIO
$10.2B
| $3.78M | 0.02% |
+20,724
| New | +$3.53M |
|
762
Ternium
TX
$10.8B
| $3.76M | 0.02% |
+155,799
| New | +$3.64M |
|
|
XHR
763
Xenia Hotels & Resorts
XHR
$1.81B
| $3.75M | 0.02% |
193,174
-171,861
| -47% | -$2.93M |
|
764
Carlyle Group
CG
$17.5B
| $3.73M | 0.02% |
+244,522
| New | +$3.78M |
|
|
GOLD
765
DELISTED
Randgold Resources Ltd
GOLD
| $3.73M | 0.02% |
+48,836
| New | +$3.87M |
|
766
Cooper Companies
COO
$14.8B
| $3.71M | 0.02% |
+84,724
| New | +$3.7M |
|
|
SPNC
767
DELISTED
Spectranetics Corp
SPNC
| $3.68M | 0.02% |
150,220
+90,220
| +150% | +$2.12M |
|
768
Brunswick
BC
$5.26B
| $3.67M | 0.02% |
67,322
-118,455
| -64% | -$5.86M |
|
|
MDRX
769
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.66M | 0.02% |
358,077
-1,279,170
| -78% | -$14.6M |
|
770
CALL
SLM Corp
SLM
$4.95B
| $3.65M | 0.02% |
+331,100
| New | +$2.97M |
|
|
CONN
771
DELISTED
Conn's Inc.
CONN
| $3.65M | 0.02% |
+288,323
| New | +$3.18M |
|
772
Columbia Sportswear
COLM
$3.08B
| $3.63M | 0.02% |
+62,287
| New | +$3.66M |
|
|
SVC
773
Service Properties Trust
SVC
$1.04B
| $3.63M | 0.02% |
22,873
+10,572
| +86% | +$1.53M |
|
774
Intel
INTC
$461B
| $3.63M | 0.02% |
100,000
-1,566,125
| -94% | -$56.1M |
|
775
Cardinal Health
CAH
$54B
| $3.62M | 0.02% |
+50,325
| New | +$3.64M |
|
Similar funds
Dmitry Balyasny's Q4 2016 Portfolio in Review
As of Q4 2016, Dmitry Balyasny held 1,603 positions worth $18.6B, up 7.6% from $17.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
Dmitry Balyasny's Q4 2016 filing shows 632 new, 338 increased, 353 reduced and 276 closed positions. Its largest new stake was Basis Energy Services, Inc.: 586,398 shares worth $20.7M. The largest sale was Eli Lilly, an estimated $187M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 9.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Dmitry Balyasny's largest Q4 2016 buy was Basis Energy Services, Inc.: 586,398 shares worth $20.7M.
- Dmitry Balyasny added most to Alcoa in Q4 2016, an estimated $98.7M increase.
- Dmitry Balyasny's biggest Q4 2016 reduction was Eli Lilly, cutting an estimated $187M.
- Dmitry Balyasny fully exited Canadian Pacific Kansas City in Q4 2016, selling an estimated $160M.
- Dmitry Balyasny's ten largest holdings make up 8.7% of its $18.6B portfolio in Q4 2016.
- Dmitry Balyasny opened 632 new positions and closed 276 in Q4 2016.
- Dmitry Balyasny's portfolio value rose 7.6% quarter-over-quarter to $18.6B.
Based on Balyasny Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.